Hypertension and Cardiovascular Remodelling in Rats Exposed to Continuous Light: Protection by ACE-Inhibition and Melatonin

Global left ventricular longitudinal strain is associated with decreased melatonin levels in patients with acute myocardial infarction: a two-dimensional speckle tracking study

(2013) Alberto Dominguez-Rodriguez et al.   BIOMARKERS

Melatonin attenuates hypertension-related proarrhythmic myocardial maladaptation of connexin-43 and propensity of the heart to lethal arrhythmias

(2013) Tamara Benova et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Experimental models of melatonin-deficient hypertension 

(2013) Fedor Simko   Frontiers in Bioscience-Landmark

Melatonin and cardioprotection in the acute myocardial infarction: A promising cardioprotective agent

(2012) Alberto Dominguez-Rodriguez et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction

(2012) Alberto Dominguez-Rodriguez et al.   JOURNAL OF PINEAL RESEARCH

Melatonina y enfermedad cardiovascular: ¿mito o realidad?

(2012) Alberto Dominguez-Rodriguez et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Intracoronary melatonin increases coronary blood flow and cardiac function through β-adrenoreceptors, MT1/MT2 receptors, and nitric oxide in anesthetized pigs

(2011) Elena Grossini et al.   JOURNAL OF PINEAL RESEARCH

A case-control study of melatonin receptor type 1A polymorphism and acute myocardial infarction in a Spanish population

(2011) Sima Samimi-Fard et al.   JOURNAL OF PINEAL RESEARCH

Melatonin as a natural ally against oxidative stress: a physicochemical examination

(2011) Annia Galano et al.   JOURNAL OF PINEAL RESEARCH

Effects of Melatonin and Pycnogenol on Small Artery Structure and Function in Spontaneously Hypertensive Rats

(2010) Rita Rezzani et al.   HYPERTENSION

Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril

(2010) Fedor Simko et al.   JOURNAL OF HYPERTENSION

Remodelling of the heart and vessels in experimental hypertension: advances in protection

(2010) Fedor Simko et al.   JOURNAL OF HYPERTENSION

Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin

(2010) Russel J Reiter et al.   JOURNAL OF HYPERTENSION

Efficacy of melatonin, mercaptoethylguanidine and 1400W in doxorubicin- and trastuzumab-induced cardiotoxicity

(2010) Mustafa Ozturk et al.   JOURNAL OF PINEAL RESEARCH

Melatonin and circadian biology in human cardiovascular disease

(2010) Alberto Dominguez-Rodriguez et al.   JOURNAL OF PINEAL RESEARCH

Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome

(2010) Marzena Koziróg et al.   JOURNAL OF PINEAL RESEARCH

Clinical Aspects of Melatonin in the Acute Coronary Syndrome

(2009) Alberto Dominguez-Rodriguez et al.   Current Vascular Pharmacology

Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats

(2009) Ludovit Paulis et al.   JOURNAL OF HYPERTENSION

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats

(2009) Fedor Simko et al.   JOURNAL OF HYPERTENSION

The circadian melatonin rhythm and its modulation: possible impact on hypertension

(2009) Russel J Reiter et al.   JOURNAL OF HYPERTENSION

Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of l-arginine and spironolactone

(2008) L. Paulis et al.   Acta Physiologica

MELATONIN REDUCES BLOOD PRESSURE IN RATS WITH STRESS-INDUCED HYPERTENSION VIA GABAARECEPTORS

(2008) Hua-Li Li et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY